- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06438094
The Influence of Non-Carious Cervical Lesions on Root Coverage
The Influence of Non-Carious Cervical Lesions on Root Coverage by Means of Coronally Advanced Flap and a Connective Tissue Graft: A Prospective Cohort Study
The goal of this prospective cohort study is to evaluate the effect of non-carious cervical lesions (NCCLs) on the outcome of root coverage therapy. The main question it aims to answer is: In gingival recessions associated with NCCLs, characterized by an undetectable cemento-enamel junction (CEJ), reconstruction of the CEJ with a cervical composite restoration, prior to root coverage surgery by means of a coronally advanced flap combined with a connective tissue graft (CAF+CTG), provides similar clinical and patient-reported outcomes, as compared to the treatment of gingival recessions associated with NCCLs, characterized by a visible CEJ, with root coverage surgery only, by means of a CAF+CTG.
In NCCLs where the CEJ is undetectable (B-type defect), the CEJ will be reconstructed before surgery with a cervical composite restoration mimicking the anatomic features of the contralateral, homologous tooth. CAF+CTG treatment will be performed in all cases. Participants will be assessed at 6 weeks, 3 months, and 6 months to evaluate clinical, volumetric, and patient-centred outcomes.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Barcelona
-
Barcelona, Barcelona, Spain, 08021
- BLASI Clínica Dental Barcelona
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Systemically healthy individuals older than 18 years old;
- Healthy periodontal status according to the AAP/EFP definition;
- Full-mouth plaque (FMPS) and bleeding scores (FMBS) ≤ 20%;
- At least one facial RT1 GR in single-rooted teeth with a minimum depth of 2 mm, associated with a NCCL;
- No history of periodontal surgery at the experimental site(s).
Exclusion Criteria:
- Pregnancy or lactation;
- Self-reported smoking ≥10 cigarettes/day;
- Metabolic diseases that negatively affect soft tissue healing (i.e., diabetes mellitus);
- Any medication that may interfere with wound healing;
- Prosthetic crown at experimental teeth;
- Ongoing orthodontic therapy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Type A gingival recession defects
Gingival recession defects that present with a visible CEJ.
These defects will receive root coverage surgery only.
|
A root coverage surgery will be performed using Zucchelli et al.'s coronally advanced flap combined with a connective tissue graft from the palate.
|
|
Experimental: Type B gingival recession defects
Gingival recession defects that do not present a visible CEJ.
A cervical composite restoration will be done prior to root coverage surgery.
|
Reconstruction of the CEJ with a composite restoration will be performed in B+ and B- defects prior to root coverage surgery.
A root coverage surgery will be performed using Zucchelli et al.'s coronally advanced flap combined with a connective tissue graft from the palate.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean Root Coverage (MRC)
Time Frame: 6 months
|
Mean root coverage assessed in percentage
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Complete Root Coverage (CRC)
Time Frame: 6 months
|
Complete Root Coverage assessed in percentage
|
6 months
|
|
Change in keratinized tissue width (ΔKTW)
Time Frame: 6 weeks, 3 months, 6 months
|
Change in keratinized tissue width assessed digitally in mm
|
6 weeks, 3 months, 6 months
|
|
Change in marginal gingival thickness (ΔMGT)
Time Frame: 6 weeks, 3 months, 6 months
|
Change in marginal gingival thickness assessed at 1, 2, and 3 mm from the gingival margin in mm
|
6 weeks, 3 months, 6 months
|
|
Change in recession depth (ΔRD)
Time Frame: 6 weeks, 3 months, 6 months
|
Change in recession depth assessed digitally in mm
|
6 weeks, 3 months, 6 months
|
|
Change in recession area (ΔRA)
Time Frame: 6 weeks, 3 months, 6 months
|
change in recession area assessed digitally in mm^2
|
6 weeks, 3 months, 6 months
|
|
Change in mucosal volume (ΔMV)
Time Frame: 6 weeks, 3 months, 6 months
|
change in mucosal volume assessed digitally in mm^3
|
6 weeks, 3 months, 6 months
|
|
Probing pocket depth (PPD)
Time Frame: 6 months
|
probing pocket depth assessed clinically in mm using a periodontal probe
|
6 months
|
|
Clinical attachment level (CAL)
Time Frame: 6 months
|
Clinical attachment level assessed clinically in mm (sum of probing pocket depth and recession)
|
6 months
|
|
Dentin sensitivity as assessed by VAS (Visual Analog Scale)
Time Frame: Initial, 6 months
|
Dentin sensitivity assessed on each tooth after directing an air blast from a triple syringe at the buccal cervical areas, maintaining a distance of 1 cm for 5 seconds, using a Visual Analog Scale [0-100]
|
Initial, 6 months
|
|
Patient aesthetic satisfaction as assessed by VAS (Visual Analog Scale)
Time Frame: 6 months
|
Patient aesthetic satisfaction assessed using a Visual Analog Scale [0-100]
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Gonzalo Blasi, Universitat Internacional de Catalunya
- Principal Investigator: José Nart, Universitat Internacional de Catalunya
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PER-ECL-2022-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.